Drug delivery device

• US 20020197298A1
• Filed: 07/01/2002
• Published: 12/26/2002
• Est. Priority Date: 10/21/1999
• Status: Active Grant

• Current Assignee: Novartis Ag
• Original Assignee: Alcon Incorporated
• Inventors: Yaacobi, Yoseph
• Granted Patent: US 6,808,719 B2
• Time in Patent Office: Days
• US Class Current: 424/425
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61K 9/0051 Ocular inserts, ocular implants
• CPC Class Codes: A61P 27/02 Ophthalmic agents

Abstract

Drug delivery devices, and methods of delivering pharmaceutically active agents to a target tissue within a body using such devices, are disclosed. One drug delivery device includes a body having an internal surface for placement proximate a target tissue and a well having an opening to the internal surface. An inner core comprising a pharmaceutically active agent is disposed in the well.

Claims

1. A drug delivery device, comprising:

a body having an internal surface for placement proximate a target tissue and a well having an opening to said internal surface; and

an inner core disposed in said well comprising a pharmaceutically active agent.